This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Currax Pharmaceuticals LLC, Nalpropion Pharmaceuticals LLC. Active years: 2025-2026.
Company Filing History:
Years Active: 2025-2026
Title: Rob Churchill: Innovator in Pharmaceutical Formulations
Introduction
Rob Churchill is an accomplished inventor based in Nolensville, TN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations that address critical health issues.
Latest Patents
Rob Churchill holds a patent for "Pharmaceutical formulations comprising naltrexone and/or bupropion." This patent describes innovative pharmaceutical formulations that can include extended-release, multilayer beads. These formulations are designed for effective administration in the treatment of overweight or obesity, showcasing Rob's commitment to improving health outcomes.
Career Highlights
Rob is currently associated with Currax Pharmaceuticals LLC, where he applies his expertise in pharmaceutical development. His work focuses on creating effective solutions that can enhance patient care and treatment efficacy.
Collaborations
Rob collaborates with talented professionals in the industry, including his coworker Aaron Chesnut. Together, they contribute to advancements in pharmaceutical formulations and research.
Conclusion
Rob Churchill's innovative work in pharmaceutical formulations exemplifies his dedication to addressing health challenges through science and technology. His contributions are paving the way for more effective treatments in the pharmaceutical industry.